Thursday, 29 June 2017

Catalent opens new clinical supply facility on its Japan campus

09 June 2016 | News | By BioSpectrum Bureau

Catalent opens new clinical supply facility on its Japan campus

US-based Catalent Pharma Solutions has announced the opening of its clinical supply facility, located within its 200,000 sq ft-cGMP site in Kakegawa, Japan.

The site will serve the needs of both domestic and global clinical trial sponsors with services including secondary packaging and labeling, clinical storage, distribution, project management and clinical supply management, and will complement the capabilities of other Catalent facilities in the Asia-Pacific region.

"There is significant demand for Catalent's clinical supply services in Japan and across the Asia-Pacific region, and we built this facility with our new Demand Led Supply model in mind, to bring customers greater speed and flexibility in their clinical supply chains," commented Wetteny Joseph, Catalent's President of Clinical Supply Services. "We are proud of the dedicated team that brought this facility online, and look forward to the first projects starting there later this month."

Catalent also indicated that the company has additional clinical supply facilities in the US, UK, Germany, Singapore, and China, and an extended network of over 50 audited depots. Catalent says its team has the capability and expertise to handle a broad range of international compliance and distribution requirements, which can help to expedite clinical trials and ensure that customers are reliably supplied where and when needed around the globe.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls